Cargando…

High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target

Anti-apoptotic protein-5 (API-5) is a survival protein interacting with the protein acinus, preventing its cleavage by caspase-3 and thus inhibiting apoptosis. We studied the effect of targeting API-5 in chemoresistant triple negative breast cancers (TNBCs), to reverse chemoresistance. 78 TNBC biops...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bousquet, Guilhem, Feugeas, Jean-Paul, Gu, Yuchen, Leboeuf, Christophe, Bouchtaoui, Morad El, Lu, He, Espié, Marc, Janin, Anne, Benedetto, Melanie Di
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859922/ https://www.ncbi.nlm.nih.gov/pubmed/31762939 http://dx.doi.org/10.18632/oncotarget.27312

Ejemplares similares

Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer
por: Bousquet, Guilhem, et al.
Publicado: (2017)

Targeting Cancer Stem Cells to Overcome Chemoresistance
por: Nunes, Toni, et al.
Publicado: (2018)

Increased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodes
por: Furet, Elise, et al.
Publicado: (2017)

Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma
por: Bousquet, Guilhem, et al.
Publicado: (2015)

EGFR is involved in dermatofibrosarcoma protuberans progression to high grade sarcoma
por: Osio, Amélie, et al.
Publicado: (2018)

Increased risk of brain metastases among patients with melanoma and PROM2 expression in metastatic lymph nodes
por: Nguyen, Thuy Thi, et al.
Publicado: (2020)

Individual xenograft as a personalized therapeutic resort for women with metastatic triple-negative breast carcinoma
por: Bousquet, Guilhem, et al.
Publicado: (2014)

Metastatic clear-cell renal cell carcinoma: a frequent NOTCH1 mutation predictive of response to anti-NOTCH1 CB-103 treatment
por: Bui, Thi Oanh, et al.
Publicado: (2023)

Re‐exploring immune‐related side effects of docetaxel in an observational study: Blood hypereosinophilia
por: Hamdan, Diaddin, et al.
Publicado: (2019)

Genomics applied to the treatment of breast cancer
por: Hamdan, Diaddin, et al.
Publicado: (2019)

Expression of angiopoietin-like 4 fibrinogen-like domain (cANGPTL4) increases risk of brain metastases in women with breast cancer
por: Dao, Tu, et al.
Publicado: (2020)

A digestive allergic reaction with hypereosinophilia imputable to docetaxel in a breast cancer patient: a case report
por: Hamdan, Diaddin, et al.
Publicado: (2015)

Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients
por: Verneuil, Laurence, et al.
Publicado: (2015)

Micromolecular methods for diagnosis and therapeutic strategy: a case study
por: Elbouchtaoui, Morad, et al.
Publicado: (2018)

Pulsed-laser irradiation of multifunctional gold nanoshells to overcome trastuzumab resistance in HER2-overexpressing breast cancer
por: Nunes, Toni, et al.
Publicado: (2019)

Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting
por: Romero, Martha, et al.
Publicado: (2016)

Reactive resistance to anti-angiogenic drugs
por: Bousquet, Guilhem, et al.
Publicado: (2015)

The fate of chemoresistance in triple negative breast cancer (TNBC)
por: O’Reilly, Elma A., et al.
Publicado: (2015)

Novel strategies to target chemoresistant triple-negative breast cancer
por: Venkatesh, Jaganathan, et al.
Publicado: (2020)

DSTYK Enhances Chemoresistance in Triple-Negative Breast Cancer Cells
por: Ogbu, Stella C., et al.
Publicado: (2021)

Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance
por: Robinson, Prema, et al.
Publicado: (2016)

Role of ABCB1 in mediating chemoresistance of triple-negative breast cancers
por: Abd El-Aziz, Yomna S., et al.
Publicado: (2021)

MicroRNA181a Is Overexpressed in T-Cell Leukemia/Lymphoma and Related to Chemoresistance
por: Yan, Zi-Xun, et al.
Publicado: (2015)

How to Make Anticancer Drugs Cross the Blood–Brain Barrier to Treat Brain Metastases
por: Angeli, Eurydice, et al.
Publicado: (2019)

MicroRNA Profiling Implies New Markers of Chemoresistance of Triple-Negative Breast Cancer
por: Ouyang, Mao, et al.
Publicado: (2014)

CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1
por: Luo, Hong, et al.
Publicado: (2021)

Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies
por: Chakrabarty, Anindita, et al.
Publicado: (2021)

The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer
por: He, Lin, et al.
Publicado: (2021)

The Prognostic and Therapeutic Implications of the Chemoresistance Gene BIRC5 in Triple-Negative Breast Cancer
por: Adinew, Getinet M., et al.
Publicado: (2022)

Deptor Enhances Triple-Negative Breast Cancer Metastasis and Chemoresistance through Coupling to Survivin Expression()()
por: Parvani, Jenny G., et al.
Publicado: (2015)

RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer
por: Koh, Siang-Boon, et al.
Publicado: (2021)

MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance
por: Mehlich, Dawid, et al.
Publicado: (2021)

Omics Analysis of Chemoresistant Triple Negative Breast Cancer Cells Reveals Novel Metabolic Vulnerabilities
por: Kordias, Dimitris, et al.
Publicado: (2022)

The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer
por: Wang, Wei, et al.
Publicado: (2023)

Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells
por: Agnello, Lisa, et al.
Publicado: (2023)

TP53 Status and Response to Treatment in Breast Cancers
por: Varna, Mariana, et al.
Publicado: (2011)

Genomics of Breast Cancer Brain Metastases: A Meta-Analysis and Therapeutic Implications
por: Nguyen, Thuy Thi, et al.
Publicado: (2023)

The POLR3G Subunit of Human RNA Polymerase III Regulates Tumorigenesis and Metastasis in Triple-Negative Breast Cancer
por: Lautré, Wiebke, et al.
Publicado: (2022)

Drug resistance-related sunitinib sequestration in autophagolysosomes of endothelial cells
por: Wu, Shuang, et al.
Publicado: (2019)

Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
por: Cazet, Aurélie S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oro8ejkij0lm9l09r3d07du1co